Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
23Andme Holding Co.
(NQ:
ME
)
0.2955
+0.0055 (+1.90%)
Streaming Delayed Price
Updated: 1:01 PM EDT, Oct 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,423,381
Open
0.2900
Bid (Size)
0.2955 (11)
Ask (Size)
0.2956 (1)
Prev. Close
0.2900
Today's Range
0.2860 - 0.2991
52wk Range
0.2700 - 1.020
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
23andMe Announces 1-for-20 Reverse Stock Split
October 11, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Announces Mathew Knowles as New Brand Ambassador
October 08, 2024
Collaboration to help increase awareness of the power of genetic testing when it comes to learning about personal health risks
From
23andMe, Inc.
Via
GlobeNewswire
Performance
YTD
-67.47%
-67.47%
1 Month
-13.09%
-13.09%
3 Month
-39.17%
-39.17%
6 Month
-26.42%
-26.42%
1 Year
-66.76%
-66.76%
More News
Read More
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants
October 02, 2024
Via
Benzinga
Topics
Data Breach
Exposures
Information Security
12 Health Care Stocks Moving In Friday's After-Market Session
September 27, 2024
Via
Benzinga
23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating
September 25, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time
September 18, 2024
Via
Benzinga
General Mills, Steelcase And 3 Stocks To Watch Heading Into Wednesday
September 18, 2024
Via
Benzinga
Independent Directors of 23andMe Resign from Board
September 17, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial
September 15, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study
September 15, 2024
From
23andMe, Inc.
Via
GlobeNewswire
One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations
September 12, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024
September 03, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
August 29, 2024
Via
Benzinga
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
August 28, 2024
From
23andMe, Inc.
Via
GlobeNewswire
ME Stock Earnings: 23andMe Holding Beats EPS, Misses Revenue for Q1 2025
August 08, 2024
Via
InvestorPlace
23andMe Reports First Quarter Fiscal 2025 Financial Results
August 08, 2024
From
23andMe, Inc.
Via
GlobeNewswire
ME Stock Alert: CEO Anne Wojcicki Enters $200 Million Buyout Offer for 23andMe
August 02, 2024
Via
InvestorPlace
23andMe Special Committee responds to CEO’s take-private proposal
August 02, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Announces CEO’s Take-Private Proposal
August 01, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe to Report Q1 FY2025 Financial Results
July 25, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research
July 25, 2024
From
23andMe, Inc.
Via
GlobeNewswire
The 3 Best Personalized Nutrition Stocks to Buy Now
July 24, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
23ANDME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates 23andMe Holding Co. - ME
July 19, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
3 High-Dividend Stocks to Buy if You Are Seeking Consistent Payouts
July 11, 2024
Via
InvestorPlace
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
June 28, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.